# Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00041314** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** exisulind
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00041314
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10-04
- **Primary completion:** 2005-07
- **Final completion:** 2007-06-15
- **Target enrollment:** — (—)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041314, "Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00041314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*